CardioKinetix Inc. Announces Successful Parachute Live Case Transmission at 2013 EuroPCR Conference
5/24/2013 6:37:18 AM
More...
|
CardioKinetix Inc. Announces Positive Clinical Data Showing Consistent Compelling Positive Results for Patients Treated With Minimally Invasive Structural Heart Device for Heart Failure
5/22/2013 11:13:09 AM
More...
|
CardioKinetix Inc. Completes $48 Million in Series E Financing
2/28/2013 7:30:17 AM
More...
|
CardioKinetix Inc. Initiates Landmark Study of First-of-Its-Kind Treatment for Heart Failure in the United States
1/8/2013 9:38:15 AM
More...
|
EU Approves All Sizes of CardioKinetix Inc.'s Heart Device
10/29/2012 8:42:39 AM
More...
|
CardioKinetix Inc. Announces Successful Live Case Transmission at TCT 2012 Conference
10/25/2012 10:09:10 AM
More...
|
CardioKinetix Inc. Announces Data From Latest European Study of Heart Failure Patients With First-of-Its-Kind Percutaneous Treatment
10/24/2012 9:42:21 AM
More...
|
CardioKinetix Inc. Receives CE Mark Approval for Full Range of Sizes for First-of-Its-Kind Percutaneous Treatment for Heart Failure
10/23/2012 7:13:13 AM
More...
|
CardioKinetix Inc. Heart Separation Device Improves 3 Year Outcomes in Heart Failure Patients
8/27/2012 9:11:50 AM
More...
|
CardioKinetix Inc. Clears 2-Year Study With Implant for Heart Failure
5/18/2012 8:07:59 AM
More...
|
|